Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06392789 · ClinicalTrials.gov registry record · NA
A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors
A NA study of Insomnia and Anatomic Stage III Breast Cancer AJCC v8, sponsored by University of Washington.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06392789 is a NA study of Insomnia and Anatomic Stage III Breast Cancer AJCC v8 that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 60 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06392789, a NA study of Insomnia and Anatomic Stage III Breast Cancer AJCC v8, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial evaluates the effect of conversational agent, Cecebot, on improving insomnia in stage I-III breast cancer survivors. Sleep disturbance ranks among the top concerns reported by breast cancer survivors and is associated with poor quality of life. Many breast cancer survivors also have decreased physical activity, which may also have a negative impact on sleep and quality of life. Cognitive behavioral therapy for insomnia (CBTi) and physical activity interventions have individually been reported to improve sleep and to have a positive impact on quality of life. Cecebot is a personalized short messaging service (SMS)-based behavioral intervention that combines CBTi and physical activity strategies that may improve sleep for breast cancer survivors.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Medical Device Usage and Evaluation
- OTHER Internet-Based Intervention
- BEHAVIORAL Cognitive Behavior Therapy for Insomnia
- OTHER Text Message-Based Navigation Intervention
Study Locations (1)
Washington
- Fred Hutch/University of Washington Cancer Consortium - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-10-04 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06392789
The ClinicalTrials.gov registry entry for NCT06392789 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (65% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Insomnia appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire Administration is the first listed.
NCT06392789 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06392789 about?
NCT06392789 is a clinical study titled "A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors". This clinical trial evaluates the effect of conversational agent, Cecebot, on improving insomnia in stage I-III breast cancer survivors. Sleep disturbance ranks among the top concerns reported by breast cancer survivors and is associated with poor quality of life. Many breast cancer survivors also h...
What is the current status of trial NCT06392789?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-10-04. Estimated completion is 2026-03-31.
What conditions does trial NCT06392789 study?
This clinical trial studies the following conditions: Insomnia, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8.
What interventions are being tested in trial NCT06392789?
The interventions under investigation include: Questionnaire Administration (OTHER), Medical Device Usage and Evaluation (OTHER), Internet-Based Intervention (OTHER), Cognitive Behavior Therapy for Insomnia (BEHAVIORAL), Text Message-Based Navigation Intervention (OTHER).
Who is sponsoring clinical trial NCT06392789?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06392789 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.